Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

OSILODROSTAT vs OXALIPLATIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

OSILODROSTAT vs OXALIPLATIN: Safety Overview

Metric OSILODROSTAT OXALIPLATIN
Total FAERS Reports 1,626 56,406
Deaths Reported 191 6,501
Death Rate 11.7% 11.5%
Hospitalizations 526 21,980
Average Patient Age 56.3 yrs 61.5 yrs
% Female Patients 70.8% 42.1%
FDA Approval Date Mar 6, 2020 Apr 28, 2011
Manufacturer Recordati Rare Diseases, Inc. Camber Pharmaceuticals, Inc.
Route ORAL INTRAVENOUS
Marketing Status Prescription Discontinued